Baxter International Inc (BAX) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Total Assets Chart for Baxter International Inc
Baxter International Inc (BAX) total assets for FY2025 were USD 20.1B, a -22.2% change from FY2024. Baxter International Inc's total assets grew from USD 6.8B in 1985 to USD 20.1B in 2025 (193.2% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 0.0%, 10-year CAGR of -0.4%, 20-year CAGR of 2.3%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $14.13B
- Implied Share Price
- $27.33
- Enterprise Value
- $21.04B
- Revenue (TTM)
- $11.47B
- EBITDA
- $1.88B
- Profit Margin
- -9.27%
- Trailing P/E
- —
- Forward P/E
- 13.77
- Price/Book (MRQ)
- 2.18
- Price/Sales (TTM)
- 1.22
- EV/EBITDA
- 27.61
- EV/Revenue
- 1.83
- Dividend Yield
- 0.71%
- Book Value
- $12.00
- Free Cash Flow (FY2025)
- $323.00M
- Free Cash Flow Yield
- 2.29%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.